Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Trends & Forecasts

Business & Regulation Advanced Medicine

The Champions of Cell & Gene Therapy

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

Manufacture Dosage Forms

Opiate Alternative

As the fires of the American opioid crisis continue to burn, can new painkillers step in?

Business & Regulation Advanced Medicine

Gearing Up for the 2022 Power List and More

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Business & Regulation Digital Technologies

Why We Need Patient-Centric Pharmacovigilance

| Saba Darvesh

Can digital approaches help improve pharmacovigilance practices?

Business & Regulation Advanced Medicine

A Kingdom United on Advanced Medicine

| Angus Stewart

A virtual meeting held by the UK Cell and Gene Catapult shared a year of progress, and thoughts on the challenges that lie ahead for British ATMPs.

Manufacture Advanced Medicine

Dreaming of an Efficient Future

Edd Stone of The Technology Partnership outlines current challenges in the cell and gene field - and what we can do about them.

Discovery & Development Drug Discovery

Slowing the Alzheimer’s Decline | The Medicine Maker Social

| Maryam Mahdi

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

Manufacture Dosage Forms

Welcome to the Era of Smart Solid Dosages

| Ali Rajabi-Siabhoomi, Gary Pond

On-dose authentication technology can help deter counterfeiters, while also helping patients better engage with their medicines.

Manufacture Bioprocessing - Upstream & Downstream

The Time is Now for Digitally Simplified Bioprocessing

| John Moore

Applying advanced technologies to bioprocessing operations will only help improve success rates.

Discovery & Development Drug Discovery

ADCs: Still Room for Improvement!

| Antoine Attinger

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register